Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE

MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE

Standard Dose
343MG;20MG;750MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE is listed in Drugs@FDA under application 022456 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE Form and strength TABLET;ORAL - 343MG;20MG;750MG Sponsor SANTARUS Submission history Latest submission status date: 2012-12-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE is listed in Drugs@FDA under application 022456 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE Form and strength TABLET;ORAL - 343MG;20MG;750MG Sponsor SANTARUS Submission history Latest submission status date: 2012-12-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE (MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE) | Drug Monograph | MedicHelpline